Qualified opioid treatment programs, practitioners and health centers can apply through June 4 for up to $200,000 a year for five years to expand access to Food and Drug Administration-approved opioid overdose treatments, the Substance Abuse and Mental Health Services Administration yesterday. SAMHSA expects to fund up to five recipients, who will partner with other prescribers in the community to develop best practices and train prescribers and individuals who support people at high risk for overdose. For more information, see the funding opportunity .

Related News Articles

Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
Adair County Health System in Greenfield, Iowa, an affiliate of MercyOne health system, sustained damage following a tornado May 21. The Iowa Hospital…
Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…